Colcrys Tablet, Film Coated
Product Images NDC 63187-292

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colcrys (NDC 63187-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (88824e10 1c76 4b45 A051 Aa8007055519 02)

A line graph comparing the percentage of patients improved across different levels of percentage improvement for three groups: COLCRYS Low-dose (1.8 mg), COLCRYS High-dose (4.8 mg), and placebo. The y-axis shows the percentage of patients improved, and the x-axis shows percent improvement intervals from >0 to ≥100.*

FDA Label Image

Colcrys 0.6mg (88824e10 1c76 4b45 A051 Aa8007055519 03)

Label for Colcrys 0.6 mg tablets, film-coated and capsule-shaped, with each tablet containing 0.6 mg of colchicine USP. The label shows distribution by Takeda Pharmaceuticals America, Inc., product of India, and packaging by Proficient Rx LP. Storage temperature and dispensing instructions are included. NDC 63187-292-03 is visible along with lot and expiration placeholders.*

FDA Label Image

Structural Formula Of Colchicine (Image 01)

Chemical structure diagram of colchicine, the active ingredient in Colcrys (colchicine) tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.